Re‐Evaluating Donor–Recipient Risk Scores in the Machine Perfusion Era Using a Large Multicenter Cohort: Do Traditional Predictive Models Still Apply?
Clinical Transplantation · 2026-08 · 40 (8)
DOI: 10.1111/ctr.70645 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Transplantation, online erschienen am 21.08.2026. Verfasst von Mingyi Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Mayo Clinic Florida, Jacksonville, Florida, USA. Hauptthemen laut MEDLINE: Liver Transplantation, Perfusion, Tissue Donors, Organ Preservation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
With increasing use of donation after circulatory death (DCD) donor grafts, the need for accurate risk‐stratification tools in liver transplantation has become critical. Machine perfusion has been shown to improve both graft and patient survival. However, existing prediction models were developed in the static cold storage (SCS) era and their accuracy when using machine perfusion remains unknown. Our study aims to study if current scoring systems can predict graft and patient survival for DCD livers preserved using normothermic machine perfusion (NMP).
Methods
This was a retrospective study of patient and graft survival in a two‐center U.S. DCD NMP cohort ( n = 532) between January 2022 and December 2024. Predicted graft and patient survival rates were obtained from established risk scoring systems, including the United Kingdom DCD risk score (UK‐DCD), Early Allograft Dysfunction (EAD) Olthoff score, Liver Graft Assessment Following Transplantation (L‐GrAFT 7 ) score, Donor Risk Index (DRI), Balance of Risk (BAR) score, and Survival Outcomes Following Liver Transplant (SOFT) score. Model discrimination was assessed using receiver operating characteristic (ROC) curves (C‐statistics). Survival outcomes across risk strata were estimated and compared using Kaplan‐Meier (KM) analysis.
Results
Across scoring systems, predicted survival consistently underestimated actual graft and patient survival in the NMP DCD cohort. The DRI, SOFT, EAD and L‐GrAFT 7 did not demonstrate predictive value. UK‐DCD predicted ≤85% and 60% 5‐year survival but 94.2% was observed; the high‐risk group predicted
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Mayo Clinic Florida, Jacksonville, Florida, USA.
- Department of Surgery, Mayo Clinic Arizona, Phoenix, Arizona, USA.
- Department of Transplant, Mayo Clinic Florida, Jacksonville, Florida, USA.
- Department of Anesthesiology, Mayo Clinic Florida, Jacksonville, Florida, USA.
Zitieren
APA
Zhang, M., Nguyen, M., Mao, S., Chadha, R., Taner, C. B., Mathur, A. K., & Croome, K. P. (2026). Re‐Evaluating Donor–Recipient Risk Scores in the Machine Perfusion Era Using a Large Multicenter Cohort: Do Traditional Predictive Models Still Apply?. Clinical Transplantation, 40(8). https://doi.org/10.1111/ctr.70645
Vancouver
Zhang M, Nguyen M, Mao S, Chadha R, Taner CB, Mathur AK, et al. Re‐Evaluating Donor–Recipient Risk Scores in the Machine Perfusion Era Using a Large Multicenter Cohort: Do Traditional Predictive Models Still Apply?. Clinical Transplantation. 2026;40(8). doi:10.1111/ctr.70645
BibTeX
@article{Zhang2026,
author = {Zhang, Mingyi and Nguyen, Michelle and Mao, Shennen and Chadha, Ryan and Taner, C Burcin and Mathur, Amit K and Croome, Kristopher P},
title = {Re‐Evaluating Donor–Recipient Risk Scores in the Machine Perfusion Era Using a Large Multicenter Cohort: Do Traditional Predictive Models Still Apply?},
journal = {Clinical Transplantation},
year = {2026},
volume = {40},
number = {8},
doi = {10.1111/ctr.70645}
}
EUVIMED